Exploring Accountability for Sustainability and SDG in the Biopharmaceutical Industry

Abstract

Concerns about the global climate change, have put sustainability, the sustainable development goals and ESG (Environment, Social and Governance) at the top of the agenda of governments and industries and the multiple stakeholder groups they interact with. This paper explores the accountability for sustainability and of ESG-ratings in a selected industry-i.e. biopharmaceuticals-supported by evidence from exemplary case companies in the biopharma ecosystem in Belgium.